BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience Emerging Biotech

NSG BioLabs Partners with Eppendorf to Propel Biotech Startups in Singapore

Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the start...

June 13, 2024 | News

Zymeworks Secures $8 Million Milestone Payment and Advances Cancer Treatment with FDA and NMPA Approvals

Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million milestone payment from Bei...

June 11, 2024 | News

EnGeneIC and Singapore Institute of Advanced Medicine Partner to Transform Cancer Treatment in Asia

EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has announce...

June 07, 2024 | News

Tyligand Bioscience Doses First Patient in Phase 1/2 Trial for Innovative KRAS G12D Cancer Therapy

Tyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the fir...

May 27, 2024 | News

Laekna Receives FDA Approval for Phase III Trial of Innovative mCRPC Treatment

Laekna, Inc. (2105.HK), a science-driven, clinical-stage biotechnology company, announced that the company has received approval from the U.S. Food an...

May 24, 2024 | News

RemeGen Announces Completion of Patient Enrollment for Two Phase III Clinical Trials of Telitacicept in China

RemeGen Co. a commercial-stage biotechnology company, recently announced significant progress of Telitacicept (RC18), that two Phase III clinical tria...

May 22, 2024 | News

Nabla Bio Secures $26 Million Series A and $550 Million in Strategic Pharma Collaborations

➢ Company builds integrated AI and wet lab technologies to design developable, selective, and functionally active protein drugs against ...

May 15, 2024 | News

Brii Biosciences Secures Breakthrough Therapy Designations for Two HBV Treatments from NMPA

Brii Biosciences Limited a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need,...

May 14, 2024 | News

Cellipont Bioservices Partners with Adva Biotechnology to Launch Innovative ADVA X3® Platform

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), and Adva Biotechnology, an Israel-based...

May 08, 2024 | News

NSG BioLabs Secures $14.5 Million Investment, Expands Partnerships to Bolster Singapore's Biotech Ecosystem

NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investme...

May 08, 2024 | News

HTL Biotechnology Acquires Modern Meadow’s Beauty and Biomedical Division, Expands into Recombinant Collagen Market

HTL Biotechnology strengthens its position as a global leader in the production and development of pharmaceutical-grade biopolymers by acquiring the beauty...

May 07, 2024 | News

Latus Bio Launches with $54 Million Series A to Advance CNS Gene Therapy

Latus Bio, a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch a...

May 03, 2024 | News

Bio Basic Asia Pacific Enhances Sanger Sequencing Services with Complimentary Re-Sequencing and Gel Analysis

Dedicated to providing precise and reliable sequencing data, Bio Basic Asia Pacific has introduced complimentary re-sequencing for all clients. Thi...

May 03, 2024 | News

Shineco Launches Innovative Product to Transform Healthcare

Shineco, a provider of technologically advanced healthcare products and services, announced that its subsidiaries Fuzhou Medashan Biotechnology Co., Ltd. a...

May 02, 2024 | News

Stay Connected